Latest Breaking News On - Verve therapeutics - Page 5 : comparemela.com

Verve Therapeutics (NASDAQ:VERV) Hits New 52-Week Low at $6 05

Verve Therapeutics (NASDAQ:VERV) Hits New 52-Week Low at $6 05
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesStifel nicolausRoyal bankDaiwa securities group incFinancial services group incVerve therapeutics incQuest partnersNewbridge financial services group incVerve therapeuticsGet free reportServices groupFinancial services groupSecurities groupVerve therapeutics daily

Verve Therapeutics, Inc (NASDAQ:VERV) Receives Average Recommendation of Moderate Buy from Brokerages

Verve Therapeutics, Inc (NASDAQ:VERV) Receives Average Recommendation of Moderate Buy from Brokerages
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesStifel nicolausHermes incInvestment managementRoyal bankSumitomo mitsui trust holdings incVanguard group incVerve therapeutics incVerve therapeutics company profileVerve therapeuticsGet free reportSumitomo mitsui trust holdingsMitsui trust holdingsGet freeVerve therapeutics daily

Verve Therapeutics, Inc (NASDAQ:VERV) Given Average Recommendation of Moderate Buy by Brokerages

Shares of Verve Therapeutics, Inc. (NASDAQ:VERV – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the eight brokerages that are presently covering the stock, Marketbeat.com reports. Two investment analysts have rated the stock with a hold rating and six have issued a buy rating on the company. The average 12-month price […]

United statesStifel nicolausRoyal bankNewbridge financial services group incQuest partnersDaiwa securities group incFinancial services group incVerve therapeutics incVerve therapeuticsGet free reportServices groupFinancial services groupSecurities groupGet freeVerve therapeutics daily

Arizona State Retirement System Has $214,000 Stake in Verve Therapeutics, Inc (NASDAQ:VERV)

Arizona State Retirement System increased its position in Verve Therapeutics, Inc. (NASDAQ:VERV – Free Report) by 24.4% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 15,360 shares of the company’s stock after purchasing an additional 3,017 shares during the period. Arizona State Retirement System’s holdings in […]

United statesStifel nicolausRoyal bankVoya investment managementVerve therapeutics company profileAmeritas investment partners incVerve therapeutics incGroup plcAmerican international group incArizona state retirement systemVerve therapeuticsFree reportState retirement systemInternational groupGeneral group plcInvestment management

Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating Verve Therapeutics, Inc for potential violations of federal securities laws

NEW YORK, April 19, 2024 /PRNewswire/ Wolf Haldenstein Adler Freeman & Herz LLP , a preeminent national shareholder rights litigation firm, announces that it is investigating claimson behalf of.

San diegoUnited statesNew yorkWolf haldensteinPrnewswire wolf haldenstein adler freeman herzVerve therapeutics incWolf haldenstein adler freeman herzVerve therapeuticsAttorney advertising